Clinical Trials Directory

Trials / Completed

CompletedNCT01690104

The Effect of PXR Activation on Blood Pressure Regulation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
22 (actual)
Sponsor
University of Oulu · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

We are investigating the effects of pregnane X receptor (PXR) activation on the regulation of blood pressure in healthy volunteers. Rifampicin (an antibiotic and also an efficient PXR activator) and placebo will be given for a week to volunteers and blood pressure is measured 24 hours using an ambulatory blood pressure monitor. Blood pressure regulating hormones will be measured in blood. Our hypothesis is that PXR is involved in the regulation of blood pressure.

Conditions

Interventions

TypeNameDescription
DRUGRifampicin
DRUGPlacebo

Timeline

Start date
2012-08-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-09-21
Last updated
2014-12-30

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01690104. Inclusion in this directory is not an endorsement.